• Endovascular Therapy Following Imaging Evaluation for Ischemic Stroke 3

  NCT02586415

  TerminatedInterventionalNot ApplicableUpdated May 21, 2019
• Prospective Registry Study of Endovascular Treatment for Acute Ischemic Stroke Patients

  NCT05988125

  Unknown statusObservationalUpdated Oct 8, 2024
• Evaluate Endovascular Treatment of Large Ischemic Stroke With Substantial Penumbra.

  NCT05539404

  TerminatedInterventionalNot ApplicableUpdated Jun 9, 2023
• Early Neurological Clinical Recovery, 3 Months After Endovascular Treatment of an Acute Ischemic Stroke

  NCT02879123

  RecruitingObservationalUpdated Jan 22, 2026
• Clinical Biological and Pharmacological Factors Influencing Stroke Outcome

  NCT00763217

  CompletedObservationalUpdated May 14, 2026
• Multidimensional Evaluation of Patients With Acute Ischemic Stroke Undergoing Pharmacological and Endovascular Revascularization Procedures for the Identification of Positive Prognostic Factors

  NCT05708079

  Unknown statusObservationalUpdated Feb 8, 2023

ClinicalTrials.gov ID

NCT03776877

Lead Sponsor

Hopital FochOTHER

Overall Status

Unknown status

Study Type

Observational

Enrollment

4,000Estimated

Last Update Posted

Aug 3, 2022Actual

Start Date

Jun 26, 2018Actual

Primary Completion Date

Dec 2022Estimated

Completion Date

Dec 2022Estimated

Official Title

Evaluation of Clinical and Imaging Criteria, and Plasma Biomarkers of Patients Receiving an Endovascular Treatment for an Acute Ischemic Stroke

Brief Summary

Study like register with biomarkers samples for patient experiencing acute ischemic stroke, to assess clinical outcomes and different factors that may affect the clinical outcomes.

• Stroke, Acute

Ages Eligible for Study

Adult (18-64)Older Adult (65+)

Sexes Eligible for Study

All

Accepts Healthy Volunteers

No

Eligibility Criteria

Inclusion Criteria:

• Age 18 and older (i.e., candidates must have had their 18th birthday)
• Neuroimaging demonstrates acute ischemic stroke with large vessel proximal with the use of neuro-thrombectomy devices intended to restore blood flow
• No upper or lower limits of the neurological severity at baseline (NIHSS).
• With or without intravenous thrombolysis
• Oral informed consent (patient and/or trustworthy person)

Non-inclusion Criteria:

• Pregnant or breast-feeding women
• Patient benefiting from a legal protection
• Non-membership of a national insurance scheme

Observational Model

Cohort

Time Perspective

Other

Lead Sponsor

Hopital FochOTHER

touze-e@chu-caen.fr

Omer.eker@chu-lyon.fr

b.gory@chu-nancy.fr

Romain.bourcier@chu-nantes.fr

Jean-christophe.FERRE@chu-rennes.fr